Advertisement

Topics

DNage Company Presentation Company Profile

01:51 EDT 23rd September 2017 | BioPortfolio

DNage is a biopharmaceutical company developing products for medical and health problems associated with ageing. The company was spun out from the Erasmus Medical Center in Rotterdam in 2004 and financed by dedicated life science investors.The Company has several products under development all based on technology and knowledge developed at the Erasmus Medical Center.

Location

DR Molenwaterplein 50
Rotterdam
3015 GE`
Netherlands

Contact

Phone: 31 715 276 354
Fax: 31 653 912 661
Email: r.strijker@dnage.nl


News Articles [1210 Associated News Articles listed on BioPortfolio]

Epigenetic Aging Clock Service Now Available Through Zymo Research and Epimorphy

IRVINE, Calif., July 11, 2017 /PRNewswire/ -- Zymo Research Corp., also known as 'The Epigenetics Company', announced today the release of a new service that can quantify biological aging in a precise...

Brookdale to Present at 2012 UBS Global Healthcare Services Conference on February 8

NASHVILLE, Tenn., Feb. 6, 2012 /PRNewswire/ -- Brookdale Senior Living Inc. (NYSE: BKD) today announced  that management will make a presentation regarding the Company at the 2012 UBS Global Heal...

Intec Pharma to Participate in BioCentury's 24th Annual NewsMakers in the Biotech Industry ...

Date and Timeof Presentation: Friday, September 8, 2017 at 10:30 a.m. Eastern time Venue:Millennium Broadway Hotel & Conference Center Format: Company presentation Read more...

Lannett To Present At The Canaccord Genuity 37th Annual Growth Conference On August 9

PHILADELPHIA, Aug. 1, 2017 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that the company will present at the Canaccord Genuity 37th Annual Growth Conference on August 9, 2017 at 4...

Bonti Announces Company Presentation At Renowned And Popular 2017 BIO International Convention

Wednesday, June 14th 2017 at 1:09pm UTC Fauad Hasan, Co-founder And CEO, To Spotlight Bonti on June 19th In San Diego, CA NEWPORT BEACH, Calif.–(BUSINESS WIRE)– Bonti, a privately-held, cl...

Jazz Pharmaceuticals to Webcast Presentation at J.P. Morgan Healthcare Conference

DUBLIN, Jan. 2, 2013 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) announced today that the company will webcast its presentation at the 31st Annual J.P. Morgan Healthcare Conference in...

Abbott to Present at Leerink Swann 2012 Global Healthcare Conference

ABBOTT PARK, Ill., Feb. 1, 2012 /PRNewswire/ -- Abbott (NYSE: ABT) will present at the Leerink Swann 2012 Global Healthcare Conference on Wednesday, Feb. 15, 2012. Thomas C. Freyman, executive vice pr...

Acadia Healthcare to Present at Baird and Wells Fargo Healthcare Conferences

Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that the Company will participate in two healthcare conferences in September. On Wednesday, September 6, 2...

PubMed Articles [705 Associated PubMed Articles listed on BioPortfolio]

Predictors of success of external cephalic version and cephalic presentation at birth among 1,253 women with non-cephalic presentation using logistic regression and classification tree analyses.

Among women with a fetus in non-cephalic presentation, external cephalic version (ECV) has been shown to reduce the rate of breech presentation at birth and cesarean birth. Compared to ECV at term, be...

The ongoing saga of the mechanism(s) of MHC class I-restricted cross-presentation.

Cross-presentation is an MHC-I antigen processing pathway that results in the presentation of peptides from exogenous viral, bacterial, parasitic, and tumor antigens and ultimately leads to priming of...

Sharing is Caring: The Case for Company-Level Collaboration in Pharmacoeconomic Modelling.

It's never too late to be infected with mumps.

Mumps, although rare since the introduction of a systematic vaccination of children in 1981 in Switzerland, occurs principally in children and is uncommon in adults. Nevertheless, it should be conside...

Pharmaceutical Marketing for Rare Diseases: Regulating Drug Company Promotion in an Era of Unprecedented Advertisement.

Clinical Trials [374 Associated Clinical Trials listed on BioPortfolio]

Effects of Bedside Compared to Outside the Room Case Presentation

Patient case presentations during ward rounds can take place at the bedside or outside the room. The best approach to patient case presentation is yet unclear. Thus, the overall aim of thi...

Epidemiology of Cardiovascular and Non-Cardiovascular Risk In Chicago

To continue the comprehensive research program on the epidemiology of cardiovascular and other major chronic diseases, including cancer and diabetes, in four Chicago population cohorts. T...

Presentation of Lumbar Disc and Reduction of Symptoms

The trial aims to assess the hypothesis that presentation of the disc material to the patient following a lumbar microdiscectomy would positively influence the improvement in their leg and...

Immunogenicity and Safety of Kinrix + MMR With and Without Varicella Vaccine in Healthy Children 4-6 Years

The purpose of the study is to evaluate the immunogenicity and safety of Kinrix when co-administered with varicella (Varivax® [varicella virus vaccine live], Merck and Company) and MMR va...

Presenting Summary Information From Cochrane Systematic Reviews

The objective of the investigators study is to evaluate the efficacy of infographics in presenting information, in terms of understanding and remembering research results, compared to stan...

Companies [1425 Associated Companies listed on BioPortfolio]

DNage Company Presentation

DNage is a biopharmaceutical company developing products for medical and health problems associated with ageing. The company was spun out from the Erasmus Medical Center in Rotterdam in 2004 and finan...

Nanodisc, Inc.

Nanodisc, Inc. owns an exclusive, world-wide commercial license to all applications of Nanodiscs™ – nano scale, discoidal structures composed of specially engineered proteins and phosphol...

TapImmune Inc.

TapImmune Inc. is an immunotherapy company specializing in the development of innovative vaccine technologies for the treatment of cancer and infectious disease. The Company’...

TapImmune, Inc.

TapImmune Inc. is an immunotherapy company specializing in the development of innovative vaccine technologies for the treatment of cancer and infectious disease. The Company’...

Projection Presentation Technology

Projection was founded in the Washington, DC area in 1971 by David Campbell. In the last three decades, Mr. Campbell has successfully expanded his company into 19 cities across the country and current...

More Information about "DNage Company Presentation" on BioPortfolio

We have published hundreds of DNage Company Presentation news stories on BioPortfolio along with dozens of DNage Company Presentation Clinical Trials and PubMed Articles about DNage Company Presentation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of DNage Company Presentation Companies in our database. You can also find out about relevant DNage Company Presentation Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...


Corporate Database Quicklinks



Searches Linking to this Company Record